David Young
Dr Young is Chief Scientific officer of Questcor Pharmaceuticals, Inc.,
a biopharmaceutical company focused on providing prescription drugs for
the treatment of rare central nervous system and inflammatory disorders.
He was previously executive director and President, US Operations, of
AGI.
